Skip to main content
. 2013 Aug 23;10:106. doi: 10.1186/1742-2094-10-106

Figure 1.

Figure 1

Surface marker expression in MSCs. MSCs were confirmed by flow cytometry analysis after three passages as positive for CD44 (99.01%), CD90 (99.28%) and CD105 (97.71%), with low positivity for CD14 (0.79%), CD34 (0.78%), CD45 (0.67%) and HLA-DR (1.11%).